Company intelligence / Profile preview

SINOPEG

Xiamen, Fujian, Chinasinopeg.com ↗
Ownership
Private
Employees
~78
Development stage
Other
01

Overview

SINOPEG is a China-based drug delivery and medical materials company focused on research, development, manufacturing, and sales of PEG derivatives, PEGylation reagents, PEGylated lipids, lipid nanoparticle excipients, block copolymers, hydrogels, and related pharmaceutical materials. The company positions itself as a supplier and development partner for long-acting protein and peptide drugs, mRNA vaccines, small nucleic acid therapeutics, gene therapies, liposomal drugs, ADCs, PROTACs, and medical devices. In addition to catalog products, it offers custom synthesis, CDMO support, and formulation-related solutions for pharmaceutical and biotech customers. Its business appears to be primarily tools, excipients, and delivery-enabling materials rather than a traditional proprietary therapeutic pipeline.

Therapeutic areas
OncologyEndocrinologyRare DiseasesInfectious Diseases
Modalities
BiologicPeptidesRNA therapymRNA-based drugsGene therapyNanoparticleLipid nanoparticle delivery therapyHydrogel-based drug delivery therapySmall molecule
Industry
Chemicals & Materials

Beyond the preview

Go deeper on SINOPEG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SINOPEG.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call